Stem Cells and Disease Modelling

Stem cells offer a powerful platform for modeling human diseases in the laboratory, providing researchers with valuable tools to study disease mechanisms, identify novel therapeutic targets, and develop more effective treatments. By reprogramming adult cells into induced pluripotent stem cells (iPSCs), scientists can generate patient-specific cell lines that carry the genetic mutations associated with a particular disease. These iPSCs can then be differentiated into disease-relevant cell types, such as neurons for neurological disorders, cardiomyocytes for heart diseases, or hepatocytes for liver disorders. This approach allows researchers to recapitulate key aspects of disease pathology in a controlled, laboratory setting.

Stem cell-based disease models enable researchers to:

  • Study Disease Mechanisms
  • Screen for Drug Candidates
  • Personalized Medicine
  • Disease Monitoring and Biomarker Discovery

    Related Conference of Stem Cells and Disease Modelling

    April 16-17, 2026

    19th World Congress on Stem Cell Research

    Tokyo, Japan
    June 08-09, 2026

    9th Global Conference on Cell and Gene Therapy

    Rome, Italy
    June 15-16, 2026

    22nd Global Summit on Stem Cell & Regenerative Medicine

    Amsterdam, Netherlands
    June 15-16, 2026

    13th World Congress on Epigenetics and Chromosome

    Paris, France
    June 18-19, 2026

    19th International Conference on Genomics & Pharmacogenomics

    Singapore City, Singapore
    September 25-26, 2025

    6th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada

    Stem Cells and Disease Modelling Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in